LD3

Spring Call 2022 - closed

MRC CiC/Leicester Drug Discovery and Diagnostics (LD3) Spring Call - closed

Accelerating translational research at the University of Leicester 

Elevator pitch for top-ranked PIs and funding decision: TBC

We are looking to fund innovative, translational projects at various stages of development, from target validation/Proof of Concept studies to pre-clinical testing.

Priority areas should accelerate innovative translational research towards the development of novel medicines, therapies, devices, diagnostic tests and precision medicine approaches in Leicester.

Please note: MRC terms mean that this cannot be used for bridging salary funding between grants.

Award value: up to 70k.

Duration: projects should be up to 12 months and must finish by end of July 2023.   

For more information about the award and application process, please contact: Dr Carl Edwards, LD3 Research Manager ce133@leicester.ac.uk.

UKRI medical research council logo

Back to top
MENU